Thematic

  • -Tout-
  • COVID-19
  • Multi-sectors
  • Social & Inclusive Business
  • Supporting high-potential innovative start-ups
  • Industry and Services
  • Our range of services
  • Technical Assistance
  • Education
  • Investment funds
  • Infrastructures
  • Renewable energies and energy efficiency
  • Health
  • Banks and Financial services
  • Microfinance
  • Agriculture and Agro-industry

Proparco, Biovac and Development Partners Collaborate to Support South Africa’s Vaccine Manufacturing Expansion and Advance Long-Term Health Security Across Africa

IFC, Proparco, DEG and DFC Support South African COVID-19 Vaccine Maker, Aspen
• Consortium of nine development partners to support Biovac’s expansion of its existing vaccine manufacturing plant capacity, and enable the production of Pfizer-BioNTech’s COVID-19 vaccine and other vaccines.
• Biovac to raise around $150 million (ZAR2.3 billion) to boost increased local vaccine manufacturing capacity across the African continent.
• Partners include AfDB, CDC Group, DEG, DFC, EIB, IFC, Proparco, the European Union Delegation to South Africa, and the Industrial Development Corporation of South Africa (IDC).
Published on

Proparco, IFC, DEG and DFC Support South African COVID-19 Vaccine Maker, Aspen

IFC, Proparco, DEG and DFC Support South African COVID-19 Vaccine Maker, Aspen
To support the development of vaccines for African countries, Proparco, IFC, DEG - the German development finance institution, and the U.S. International Development Finance Corporation (DFC) today announced a joint financing package for Aspen Pharmacare Holdings Limited, a leading pharmaceutical company in South Africa that is playing a major role producing COVID-19 treatment therapies and vaccines on the African continent.
Published on